» Articles » PMID: 22349148

Replication of Human Coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is Inhibited by the Drug FK506

Overview
Journal Virus Res
Specialty Microbiology
Date 2012 Feb 22
PMID 22349148
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Recent research has shown that Coronavirus (CoV) replication depends on active immunophilin pathways. Here we demonstrate that the drug FK506 (Tacrolimus) inhibited strongly the growth of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E at low, non-cytotoxic concentrations in cell culture. As shown by plaque titration, qPCR, Luciferase- and green fluorescent protein (GFP) reporter gene expression, replication was diminished by several orders of magnitude. Knockdown of the cellular FK506-binding proteins FKBP1A and FKBP1B in CaCo2 cells prevented replication of HCoV-NL63, suggesting the requirement of these members of the immunophilin family for virus growth.

Citing Articles

Cyclophilin A: promising target in cancer therapy.

Jin S, Zhang M, Qiao X Cancer Biol Ther. 2024; 25(1):2425127.

PMID: 39513594 PMC: 11552246. DOI: 10.1080/15384047.2024.2425127.


Oxysterole-binding protein targeted by SARS-CoV-2 viral proteins regulates coronavirus replication.

Ma-Lauer Y, Li P, Niemeyer D, Richter A, Pusl K, von Brunn B Front Cell Infect Microbiol. 2024; 14:1383917.

PMID: 39119292 PMC: 11306179. DOI: 10.3389/fcimb.2024.1383917.


SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19.

Schwartz J, Capistrano K, Gluck J, Hezarkhani A, Naqvi A Rev Med Virol. 2024; 34(3):e2543.

PMID: 38782605 PMC: 11260190. DOI: 10.1002/rmv.2543.


Gastrointestinal presentation of COVID-19 in a pediatric heart transplant recipient.

Helal A, Elmahrouk A, Jamjoom A, Al-Ata J Cardiothorac Surg. 2024; 28(1):24.

PMID: 38624531 PMC: 7652410. DOI: 10.1186/s43057-020-00034-z.


Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case report.

Yomota M, Tanaka M, Kobayashi T, Kitano M, Ikeda S, Kanemasa Y Respirol Case Rep. 2024; 12(2):e01298.

PMID: 38379821 PMC: 10878828. DOI: 10.1002/rcr2.1298.


References
1.
Cervantes-Barragan L, Zust R, Maier R, Sierro S, Janda J, Levy F . Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity. mBio. 2010; 1(4). PMC: 2939679. DOI: 10.1128/mBio.00171-10. View

2.
Briggs C, Ott D, Coren L, Oroszlan S, Tozser J . Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1. Arch Virol. 1999; 144(11):2151-60. DOI: 10.1007/s007050050629. View

3.
Reis S, Moussatche N, Damaso C . FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture. J Appl Microbiol. 2006; 100(6):1373-80. DOI: 10.1111/j.1365-2672.2006.02855.x. View

4.
Takara K, Tsujimoto M, Ohnishi N, Yokoyama T . Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells. Biochem Biophys Res Commun. 2002; 292(1):190-4. DOI: 10.1006/bbrc.2002.6619. View

5.
Stockman L, Bellamy R, Garner P . SARS: systematic review of treatment effects. PLoS Med. 2006; 3(9):e343. PMC: 1564166. DOI: 10.1371/journal.pmed.0030343. View